Article
Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Nov 2009
Felsberg Jörg, Rapp Marion, Loeser Simon, Fimmers Rolf, Stummer Walter, Goeppert Matthias, Steiger Hans-Jacob, Friedensdorf Britta, Reifenberger Guido, Sabel Michael C
Abstract excerpt
PURPOSE: Despite multimodal aggressive treatment glioblastoma patients still face a rather poor prognosis. Recent data indicate that certain molecular markers, in particular MGMT promoter hypermethylation, are associated with response to alkylating chemotherapy and longer survival. The clinical significance of other glioblastoma-associated molecular aberrations and their relationship to MGMT promoter...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
